What are the effects of an open-label placebo?

Not Applicable

Completed

• Conditions: General health; Nocebo effect; Mental Health - Studies of normal psychology, cognitive function and behaviour

• Registration Number: ACTRN12622001570774
• Lead Sponsor: The University of Auckland

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-12-20
• Study Completion: 2023-03-15
• Last Update Posted: 12 December 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Participants are eligible to take part in this study if they are aged 18 years or older, able to fill out the questionnaires, willing to participate and fluent in the English language.

Exclusion Criteria

None.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Participants´ reporting of side effects measured with the Side Effect Attribution Scale (SEAS).[ 15 minutes and 24 hours post-intervention]

Secondary Outcome Measures

Name	Time	Method
Mood measured with the Positive and Negative Affect Schedule (PANAS) (Watson, Clark & Tellegen, 1988).[ 15 minutes and 24 hours post-intervention]